• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov6
Canaccord Genuity Analyst Reiterates Buy Rating on Seres Therapeutics Stock
14:52
Nov5
Seres Therap released FY2025 9 Months Earnings on November 5 During-Market EST, actual revenue USD 351K, actual EPS USD 2.4159
21:00
Seres Therap released FY2025 Q3 earnings during market hours on November 5 (EST), actual revenue USD 351 K (forecast USD 5.875 M), actual EPS USD 0.9366 (forecast USD 0.425)
21:00
Oct29
Seres Therap to Release FY2025 Q3 Earnings on November 5 During-Market EST, Forecast Revenue USD 5.875 M, EPS USD 0.425
00:05
Aug6
Seres Therap released FY2025 Q2 earnings during market hours on August 6 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -2.2707 (forecast USD -2.49)
20:00
Seres Therap released FY2025 Semi-Annual Earnings on August 6 During-Market EST, actual revenue USD 0, actual EPS USD 1.47
20:00

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 351 K, Net Income 8.204 M, EPS 0.9366

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -19.86 M, EPS -2.2707

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income 32.68 M, EPS 3.75

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More